Lazard Ltd
NYSE:LAZFinancial - Capital Markets
+$0.45 today
- Market cap
- $3.85B
- Beta
- 1.41
- P/E (TTM)
- 15.7
- EPS (TTM)
- $2.79
- Dividend yield
- 4.58%
Volume 1.38M
Average 1.53M
LAZ Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Lazard LtdNYSE: LAZ
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How LAZ compares with its peers on the latest reported figures
- LAZ's LTM Sep 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for LAZ, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding LAZ) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for LAZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.27B | 2.83B | 2.55B | 3.09B | 3.19B |
| Cost of Revenue | 1.9B | 1.66B | 1.95B | 2B | 2.17B |
| Gross Profit | 1.37B | 1.17B | 605.13M | 1.08B | 1.01B |
| Gross Margin | 42.0% | 41.4% | 23.7% | 35.1% | 31.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 379M | 384.87M | 430.66M | 426.66M | 118.49M |
| Operating Expenses | 648.56M | 652.34M | 685.09M | 696.62M | 597.78M |
| Depreciation & Amortization | 112.4M | 103.02M | 42.85M | 36.28M | 34.19M |
| EBITDA | 917.02M | 701.39M | 40.57M | 510.82M | 449.41M |
| EBITDA Margin | 28.1% | 24.8% | 1.6% | 16.6% | 14.1% |
| Operating Income | 723.85M | 516.85M | (79.96M) | 386.47M | 415.32M |
| Operating Margin | 22.1% | 18.3% | -3.1% | 12.5% | 13.0% |
| Interest Income | 5.55M | 29.46M | 42.02M | 53.6M | 38.49M |
| Interest Expense | 80.77M | 81.52M | 77.67M | 88.07M | 87.62M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (87.72M) |
| Income Before Tax | 723.85M | 516.85M | (79.96M) | 386.47M | 327.6M |
| Pre-Tax Margin | 22.1% | 18.3% | -3.1% | 12.5% | 10.3% |
| Income Tax Expense | 181.3M | 124.37M | (22.65M) | 99.76M | 76.58M |
| Net Income | 528.06M | 357.52M | (75.48M) | 279.91M | 236.83M |
| Net Margin | 16.2% | 12.7% | -3.0% | 9.1% | 7.4% |
| EPS (Basic) | 4.90 | 3.68 | (0.90) | 2.93 | 2.43 |
| EPS (Diluted) | 4.63 | 3.51 | (0.90) | 2.68 | 2.17 |
| Weighted Avg Shares | 106.04M | 95.66M | 88.99M | 93.14M | 97.48M |
| Weighted Avg Shares (Diluted) | 113.68M | 101M | 88.99M | 102.39M | 106.34M |
Lazard Ltd
NYSE:LAZ
Intrinsic Alpha fair value
Locked
Current Price
$39.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.